Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation

Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)

(2021) V. Yu. Mareev et al.   KARDIOLOGIYA

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

(2021) Chaolin Huang et al.   LANCET

Epstein-Barr Virus and Systemic Autoimmune Diseases

(2021) Gunnar Houen et al.   Frontiers in Immunology

COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

(2021) Katarzyna Kotfis et al.   Pharmaceuticals

SARS-CoV-2 Respiratory Co-Infections: Incidence of Viral and Bacterial Co-Pathogens

(2021) Vijay Singh et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Sequelae in Adults at 6 Months After COVID-19 Infection

(2021) Jennifer K. Logue et al.   JAMA Network Open

Positive Epstein–Barr virus detection in coronavirus disease 2019 (COVID-19) patients

(2021) Ting Chen et al.   Scientific Reports

New type of corona virus induced acute otitis media in adult

(2020) Vural Fidan   AMERICAN JOURNAL OF OTOLARYNGOLOGY

Clinical and Epidemiological Characteristics of 1,420 European Patients with mild‐to‐moderate Coronavirus Disease 2019

(2020) Jerome R. Lechien et al.   JOURNAL OF INTERNAL MEDICINE

Infarct‐like myocarditis with coronary vasculitis and aneurysm formation caused by Epstein–Barr virus infection

(2020) Cristina Chimenti et al.   ESC Heart Failure

Clinical characteristics of primary and reactivated Epstein‐Barr virus infection in children

(2020) Ying Yang et al.   JOURNAL OF MEDICAL VIROLOGY

Management of post-acute covid-19 in primary care

(2020) Trisha Greenhalgh et al.   BMJ-British Medical Journal

Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study

(2020) Jiao Liu et al.   Annals of Intensive Care

COVID toes: where do we stand with the current evidence?

(2020) Marie Baeck et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19

(2020) Eve Garrigues et al.   JOURNAL OF INFECTION

How and Why Patients Made Long Covid

(2020) Felicity Callard et al.   SOCIAL SCIENCE & MEDICINE

EBV DNA increase in COVID-19 patients with impaired Lymphocyte subpopulation count

(2020) Stefania Paolucci et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Epstein-Barr virus strain variation and cancer

(2019) Teru Kanda et al.   CANCER SCIENCE

May syphilis protect against human papillomavirus infection? An example of heterologous immunity

(2019) Francesco Drago et al.   GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

674

(2018) Bibi Aneesah Jaumally et al.   CRITICAL CARE MEDICINE

Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma

(2018) W. K. Jacky Lam et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update

(2018) Maria K. Smatti et al.   Frontiers in Oncology

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

(2017) K.C. Allen Chan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epstein-Barr virus strains and variations: Geographic or disease-specific variants?

(2016) Marco Neves et al.   JOURNAL OF MEDICAL VIROLOGY

Spironolactone blocks Epstein–Barr virus production by inhibiting EBV SM protein function

(2016) Dinesh Verma et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An elderly patient with chronic active Epstein–Barr virus infection with mixed cryoglobulinemia and review of the literature

(2014) Kunihiro Ichinose et al.   Modern Rheumatology

Evidence for the Role of Epstein Barr Virus Infections in the Pathogenesis of Acute Coronary Events

(2013) Philip F. Binkley et al.   PLoS One

Seroprevalence of Epstein-Barr Virus Infection in U.S. Children Ages 6-19, 2003-2010

(2013) Jennifer Beam Dowd et al.   PLoS One

Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections

(2011) O. A. Odumade et al.   CLINICAL MICROBIOLOGY REVIEWS

Long-Term Administration of Valacyclovir Reduces the Number of Epstein-Barr Virus (EBV)-Infected B Cells but Not the Number of EBV DNA Copies per B Cell in Healthy Volunteers

(2009) Y. Hoshino et al.   JOURNAL OF VIROLOGY